heme has been researched along with Duodenal Ulcer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shkatova, EIu; Vakhrushev, IaM | 1 |
| Kazimka, LO; Moĭseienko, VO; Nykula, TD; Shevchuk, SH | 1 |
| Smolianinov, AB | 1 |
1 trial(s) available for heme and Duodenal Ulcer
| Article | Year |
|---|---|
[Therapeutic efficiency of a combined use of low-intensity laser radiation and actovegin in gastroduodenal ulcers with inhibited cicatrix formation].
Topics: Adult; Aged; Anti-Ulcer Agents; Blood; Cicatrix; Combined Modality Therapy; Duodenal Ulcer; Female; Heme; Humans; Injections, Intramuscular; Low-Level Light Therapy; Male; Middle Aged; Stomach Ulcer; Treatment Outcome; Wound Healing | 2003 |
2 other study(ies) available for heme and Duodenal Ulcer
| Article | Year |
|---|---|
[The use of actovegin in peptic ulcer].
Topics: Adult; Anti-Ulcer Agents; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Female; Heme; Humans; Injections, Intramuscular; Male; Middle Aged; Remission Induction; Stomach Ulcer | 1993 |
[Actovegin treatment of duodenal ulcer associated with ischemic heart disease and diabetes mellitus].
Topics: Adenosine Triphosphate; Adult; Anti-Ulcer Agents; Biological Transport; Diabetes Complications; Diabetes Mellitus; Drug Administration Routes; Duodenal Ulcer; Duodenoscopy; Female; Glucose; Heme; Humans; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Secondary Prevention; Treatment Outcome | 2000 |